Advertisement News Archives - Page 1160 of 5232 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 13, 2026

Akeso secures China NMPA authorisation for ivonescimab combo

Summit Therapeutics’ partner Akeso has secured China’s National Medical Products Administration (NMPA) authorisation for the use of ivonescimab in combination with chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer (NSCLC) patients.

Akeso secures China NMPA authorisation for ivonescimab combo